Centrexion Therapeutics' Convertible Note - III Round

Centrexion Therapeutics raised a round of funding on June 21, 2016.

Centrexion Therapeutics is focused on developing new treatments for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.…

Articles about Centrexion Therapeutics' Convertible Note - III Round: